STOCK TITAN

Heska Third Quarter 2022 Financial Results and Earnings Call Scheduled for November 8, 2022

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

Heska Corporation (NASDAQ: HSKA) will announce its Q3 2022 financial results on November 8, 2022, before market opening. An earnings call is scheduled for 9 a.m. MT / 11 a.m. ET the same day. Investors can participate by dialing in or via live webcast on the company's investor relations site. A replay of the call will be available starting at 2 p.m. ET on November 8.

The company specializes in advanced veterinary diagnostics and has a diverse product portfolio spanning diagnostics and healthcare solutions.

Positive
  • Pending Q3 2022 earnings report could provide insights into revenue growth.
  • Scheduled earnings call allows for direct engagement with investors.
Negative
  • None.

LOVELAND, Colo., Oct. 18, 2022  /PRNewswire/ -- Heska Corporation (NASDAQ: HSKA; "Heska" or the "Company"), a leading global provider of advanced veterinary diagnostic and specialty solutions, will report its third quarter 2022 financial performance in a press release before the market opens on Tuesday, November 8, 2022. The Company will also host an earnings call at 9 a.m. MT / 11 a.m. ET to discuss the results.

To access the conference call:

From within the United States, please dial 1-800-239-9838
From outside of the United States, please dial 1-323-794-2551
Reference Conference ID: 7035658

The earnings call will be webcast live from the Company's investor relations website at: Heska Corporation Third Quarter 2022 Earnings Call Webcast.

A telephonic replay will be available at 2 p.m. ET on November 8th through 11:59 p.m. ET on November 22, 2022 and the webcast will be archived on the Company's website for 90 days.

To access the replay by telephone:

From within the United States, please dial 1-844-512-2921
From outside the United States, please dial 1-412-317-6671
Reference Replay Pin Number: 7035658

About Heska
Heska Corporation (NASDAQ: HSKA) manufactures, develops and sells advanced veterinary diagnostics, informatics, and specialty healthcare solutions through its two business segments: North America and International. Both segments include Point of Care Lab testing instruments and consumables, digital imaging products, software and services, data services, allergy testing and immunotherapy, and single-use offerings such as in-clinic diagnostic tests and heartworm preventive products. The North America segment also includes private label vaccine and pharmaceutical production for third-parties, primarily for herd animal health. For more information, please visit www.heska.com.

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/heska-third-quarter-2022-financial-results-and-earnings-call-scheduled-for-november-8-2022-301651800.html

SOURCE Heska Corporation

FAQ

When will Heska report its Q3 2022 earnings?

Heska will report its Q3 2022 earnings on November 8, 2022.

What time is the Heska earnings call scheduled for?

The earnings call is scheduled for 9 a.m. MT / 11 a.m. ET on November 8, 2022.

How can I access the Heska earnings call?

You can access the earnings call by dialing in or joining the live webcast on Heska's investor relations website.

Is a replay of the Heska earnings call available?

Yes, a telephonic replay will be available from 2 p.m. ET on November 8 until 11:59 p.m. ET on November 22, 2022.

HSKA

NASDAQ:HSKA

HSKA Rankings

HSKA Latest News

HSKA Stock Data

1.31B
10.24M
Biological Product (except Diagnostic) Manufacturing
Manufacturing
Link
US
Loveland